Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
NEUROLOGY	O
Allergies:	O
amoxicillin	O
Attending:	O
___	O
Chief	O
Complaint:	O
Right	O
face	O
weakness	O
and	O
difficulty	O
speaking	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
is	O
a	O
___	O
man	O
with	O
a	O
history	O
of	O
HTN,	O
HLD,	O
COPD,	O
prediabetes,	O
CEAx2,	O
and	O
dementia	B-Dementia
who	O
presents	O
with	O
left	O
frontal	O
IPH.	B-Intracranial_haemorrhage
He	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
when	O
he	O
was	O
picked	O
up	O
by	O
his	O
son	O
from	O
his	O
nursing	B-Lives_in_carehome
home	B-Lives_in_carehome
~11:30am	O
this	O
morning.	O
At	O
~12:30pm,	O
while	O
at	O
his	O
daughter's	O
house,	O
after	O
lunch	O
he	O
was	O
noted	O
to	O
have	O
right	O
lower	O
facial	O
droop,	O
was	O
drooling,	O
and	O
aphasic	O
(non-sense	O
words).	O
He	O
appeared	O
to	O
be	O
aware	O
that	O
his	O
words	O
were	O
not	O
making	O
sense,	O
and	O
this	O
distressed	O
him.	O
He	O
was	O
unsteady	O
on	O
his	O
feet,	O
and	O
his	O
son	O
helped	O
him	O
to	O
sit	O
down.	O
They	O
called	O
___	O
and	O
he	O
was	O
taken	O
to	O
___	O
where	O
CT	B-Intracranial_haemorrhage
showed	O
2.6x1.6cm	O
left	O
frontal	O
IPH.	B-Intracranial_haemorrhage
He	O
was	O
then	O
transferred	O
to	O
___	O
for	O
further	O
management.	O
He	O
was	O
significantly	O
agitated	O
prior	O
to	O
transfer	O
and	O
was	O
given	O
lorazepam.	O
In	O
the	O
ED	O
here,	O
he	O
received	O
Haldol.	O
Over	O
the	O
last	O
___	O
years	O
he	O
has	O
been	O
having	O
progressively	O
increasing	O
difficulty	B-Dementia
with	B-Dementia
his	B-Dementia
memory,	B-Dementia
repeating	O
himself,	O
getting	O
lost	O
in	O
his	O
own	O
building,	O
and	O
having	O
difficulty	O
with	O
his	O
finances.	O
He	O
had	O
been	O
living	O
independently,	O
but	O
in	O
___	O
moved	O
to	O
a	O
nursing	B-Lives_in_carehome
home.	B-Lives_in_carehome
He	O
has	O
a	O
history	O
of	O
seizure,	B-Seizures
the	O
first	O
occurring	O
___	O
years	O
ago	O
in	O
the	O
setting	O
of	O
abrupt	O
alcohol	O
discontinuation	O
(which	O
he	O
quit	O
permanently	O
after	O
then).	O
In	O
___,	O
he	O
had	O
an	O
episode	O
of	O
"blanking	O
out"	O
for	O
which	O
he	O
presented	O
to	O
___	O
and	O
MRI	O
showed	O
evidence	O
of	O
prior	O
strokes.	O
He	O
was	O
started	O
on	O
oxcarbazepine.	O
(His	O
neurologist	O
is	O
Dr.	O
___	O
in	O
___.)	O
Past	O
Medical	O
History:	O
Alcoholism	O
(quit	O
___	O
years	O
ago)	O
HTN	O
COPD	O
HLD	O
Pre-diabetes	O
CEAx2	O
___	O
at	O
___	O
Social	O
History:	O
Formerly	O
worked	O
as	O
___.	O
Quit	O
smoking	O
___	O
years	O
ago	O
after	O
partial	O
lung	O
mass	O
removal	O
later	O
determined	O
to	O
be	O
non-cancerous.	O
Quit	O
alcohol	O
___	O
years	O
ago,	O
though	O
previously	O
heavy	O
alcoholic.	O
Health	O
care	O
proxies:	O
___	O
(daughter,	O
___,	O
___	O
(son,	O
___.	O
Lives	O
in	O
___	O
Home	O
-	O
Modified	O
Rankin	O
Scale:	O
[]	O
0:	O
No	O
symptoms	O
[]	O
1:	O
No	O
significant	O
disability	O
-	O
able	O
to	O
carry	O
out	O
all	O
usual	O
activities	O
despite	O
some	O
symptoms	O
[]	O
2:	O
Slight	O
disability:	O
able	O
to	O
look	O
after	O
own	O
affairs	O
without	O
assistance	O
but	O
unable	O
to	O
carry	O
out	O
all	O
previous	O
activities	O
[x]	O
3:	O
Moderate	O
disability:	O
requires	O
some	O
help	O
but	O
able	O
to	O
walk	B-Independently_mobile
unassisted	B-Independently_mobile
[]	O
4:	O
Moderately	O
severe	O
disability:	O
unable	O
to	O
attend	O
to	O
own	O
bodily	O
needs	O
without	O
assistance	B-Has_carers
and	O
unable	B-Mobile_with_assistance
to	B-Mobile_with_assistance
walk	B-Mobile_with_assistance
unassisted	B-Mobile_with_assistance
[]	O
5:	O
Severe	O
disability:	O
requires	O
constant	O
nursing	B-Has_carers
care	B-Has_carers
and	O
attention,	O
bedridden,	B-Bed_Chairbound
incontinent	B-Urinary_incontinence
[]	O
6:	O
Dead	O
Family	O
History:	O
Unknown	O
Physical	O
Exam:	O
ADMISSION	O
EXAMINATION	O
=====================	O
Vitals:	O
T:uta	O
HR:70	O
BP:176/87	O
RR:18	O
SaO2:97	O
General:	O
Sedated,	O
in	O
wrist	O
restraints.	O
HEENT:	O
NCAT,	O
no	O
oropharyngeal	O
lesions,	O
neck	O
supple	O
___:	O
Well	O
perfused.	O
Pulmonary:	O
Breathing	O
comfortably	O
on	O
room	O
air.	O
Extremities:	O
Warm,	O
no	O
edema	O
Neurologic	O
Examination:	O
-	O
Mental	O
status:	O
Sedated.	O
No	O
response	O
to	O
voice.	O
Withdraws	O
to	O
noxious	O
in	O
all	O
four	O
extremities.	O
-	O
Cranial	O
Nerves:	O
PERRL.	O
VOR+.	O
Grimace	O
symmetric.	O
-	O
Sensorimotor:	O
All	O
four	O
extremities	O
antigravity.	O
Moves	O
left	O
arm	O
more	O
briskly	O
than	O
right.	O
DISCHARGE	O
EXAMINATION	O
=====================	O
Vitals:	O
Temp:	O
98.3	O
(Tm	O
98.3),	O
BP:	O
123/73	O
(109-123/64-73),	O
HR:	O
78	O
(67-121),	O
RR:	O
18,	O
O2	O
sat:	O
96%	O
(92-96),	O
O2	O
delivery:	O
RA	O
General:	O
alert,	O
cooperative,	O
in	O
NAD	O
HEENT:	O
NC/AT,	O
no	O
scleral	O
icterus	O
noted,	O
MMM	O
Pulmonary:	O
no	O
tachypnea	O
or	O
increased	O
WOB	O
Cardiac:	O
skin	O
warm,	O
well-perfused	O
Abdomen:	O
ND	O
Extremities:	O
symmetric,	O
no	O
edema	O
Neurologic:	O
-Mental	O
Status:	O
Alert,	O
cooperative.	O
Improved	O
expressive	O
aphasia,	O
naming	O
intact	O
to	O
high-	O
and	O
low-frequency	O
objects	O
on	O
stroke	O
card.	O
Reading	O
impaired.	O
Speech	O
dysarthric.	O
Able	O
to	O
follow	O
midline	O
and	O
appendicular	O
commands.	O
-Cranial	O
Nerves:	O
EOMI.	O
R	O
NLFF.	O
Hearing	O
intact	O
to	O
conversation.	O
Palatal	O
elevation	O
symmetric.	O
Tongue	O
protrusion	O
in	O
midline.	O
-Sensorimotor:	O
Maintains	O
BUE	O
against	O
gravity,	O
full	O
power	O
in	O
IPs	O
and	O
L	O
TA,	O
4+/5	O
in	O
R	O
TA	O
(though	O
exam	O
somewhat	O
limited	O
by	O
inattention).	O
-DTRs:	O
___.	O
-Coordination:	O
Deferred.	O
Pertinent	O
Results:	O
___	O
07:25AM	O
BLOOD	O
WBC-10.3*	O
RBC-3.12*	O
Hgb-9.7*	O
Hct-30.4*	O
MCV-97	O
MCH-31.1	O
MCHC-31.9*	O
RDW-15.3	O
RDWSD-54.9*	O
Plt	O
___	O
___	O
07:25AM	O
BLOOD	O
Glucose-95	O
UreaN-35*	O
Creat-1.0	O
Na-147	O
K-4.0	O
Cl-105	O
HCO3-29	O
AnGap-13	O
___	O
06:00AM	O
BLOOD	O
Calcium-9.1	O
Phos-4.5	O
Mg-2.2	O
___	O
05:15PM	O
URINE	O
Color-Straw	O
Appear-Clear	O
Sp	O
___	O
___	O
05:15PM	O
URINE	O
Blood-MOD*	O
Nitrite-NEG	O
Protein-TR*	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.5	O
Leuks-SM*	O
___	O
05:15PM	O
URINE	O
RBC-9*	O
WBC-9*	O
Bacteri-FEW*	O
Yeast-NONE	O
Epi-0	O
___	O
3:00	O
pm	O
BLOOD	O
CULTURE	O
2	O
OF	O
2.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
1:00	O
pm	O
BLOOD	O
CULTURE	O
#1.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
5:15	O
pm	O
URINE	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
8:17	O
___	O
CTA	O
HEAD	B-Intracranial_haemorrhage
AND	O
CTA	O
NECK	O
1.	O
Unchanged	O
left	O
frontal	B-Intracranial_haemorrhage
lobe	B-Intracranial_haemorrhage
hematoma	B-Intracranial_haemorrhage
with	O
surrounding	O
edema.	O
2.	O
Chronic	O
infarctions	O
with	O
no	O
evidence	O
of	O
recent	O
ischemic	O
infarction.	O
3.	O
Normal	O
appearance	O
of	O
the	O
intracranial	O
arteries.	O
4.	O
Atheromatous	O
changes	O
in	O
the	O
carotid	O
arteries	O
and	O
a	O
hypoplastic	O
right	O
vertebral	O
artery.	O
___	O
12:27	O
___	O
CHEST	O
(PORTABLE	O
AP)	O
Compared	O
to	O
chest	O
radiographs	O
since	O
___	O
most	O
recently	O
___.	O
Severe	O
elevation	O
left	O
hemidiaphragm	O
is	O
chronic,	O
displacing	O
the	O
heart	O
to	O
the	O
right,	O
but	O
mild	O
cardiomegaly	O
has	O
probably	O
developed,	O
accompanied	O
by	O
distension	O
of	O
mediastinal	O
veins.	O
Pulmonary	O
circulation	O
however	O
is	O
normal	O
and	O
there	O
is	O
no	O
pulmonary	O
edema	O
or	O
appreciable	O
pleural	O
effusion,	O
and	O
no	O
findings	O
to	O
suggest	O
pneumonia.	B-Lower_respiratory_tract_infection
___	O
9:18	O
___	O
CT	O
HEAD	B-Intracranial_haemorrhage
W/O	O
CONTRAST	O
Redemonstration	O
of	O
left	O
frontal	O
intraparenchymal	B-Intracranial_haemorrhage
hematoma	B-Intracranial_haemorrhage
with	O
a	O
small	O
subarachnoid	B-Intracranial_haemorrhage
component,	O
without	O
significant	O
mass	O
effect.	O
___	O
2:16	O
___	O
VIDEO	O
OROPHARYNGEAL	O
SWALLOW	O
Penetration	O
and	O
aspiration.	O
Brief	O
Hospital	O
Course:	O
___	O
man	O
with	O
history	O
notable	O
for	O
HTN,	O
HLD,	O
COPD,	O
prediabetes,	O
CEA	O
x2,	O
and	O
dementia	B-Dementia
transferred	O
from	O
___	O
after	O
presenting	O
with	O
acute-onset	O
right	O
facial	O
weakness	O
and	O
aphasia,	O
found	O
to	O
have	O
small	O
left	O
frontal	O
IPH.	O
Etiology	O
of	O
hemorrhage	B-Intracranial_haemorrhage
unclear,	O
though	O
suspect	O
cerebral	B-Intracranial_haemorrhage
amyloid	O
angiopathy	O
(particularly	O
with	O
history	O
of	O
dementia	B-Dementia
and	O
lobar	B-Intracranial_haemorrhage
hemorrhage),	B-Intracranial_haemorrhage
with	O
less	O
likely	O
alternatives	O
on	O
the	O
differential	O
including	O
hemorrhagic	O
transformation	O
of	O
a	O
prior	O
ischemic	O
infarct	O
or	O
underlying	O
vascular	O
malformation.	O
Repeat	O
___	O
on	O
the	O
second	O
day	O
of	O
admission	O
demonstrated	O
stable	O
hemorrhage.	O
Initial	O
course	O
complicated	O
by	O
hyperactive	O
delirium	B-Delirium
requiring	O
intermittent	O
doses	O
of	O
olanzapine	O
and	O
haloperidol,	O
subsequently	O
resolved	O
and	O
well-managed	O
with	O
nightly	O
quetiapine.	O
Subsequent	O
course	O
notable	O
for	O
dysphagia	O
managed	O
with	O
a	O
modified	O
diet	O
(see	O
below),	O
on	O
which	O
Mr.	O
___	O
was	O
able	O
to	O
maintain	O
adequate	O
caloric	O
intake.	O
___	O
evaluation	O
recommended	O
discharge	O
back	O
to	O
Mr.	O
___	O
long-term	O
care	O
facility	O
with	O
increased	O
assistance	B-Mobile_with_assistance
with	O
functional	O
mobility	O
and	O
use	O
of	O
rolling	O
walker.	B-Mobile_with_aid
Course	O
notable	O
for	O
hyponatremia	O
on	O
admission	O
likely	O
ascribable	O
to	O
oxcarbazepine,	O
which	O
was	O
switched	O
to	O
divalproex	O
without	O
concern	O
for	O
further	O
seizures	B-Seizures
(incidental	O
note	O
was	O
made	O
of	O
a	O
brief	O
period	O
of	O
biceps	O
tremor	O
that	O
resolved	O
with	O
resting	O
the	O
arm,	O
not	O
concerning	O
for	O
seizure).	B-Seizures
Course	O
also	O
notable	O
for	O
pyuria	O
and	O
fevers	O
ascribed	O
to	O
a	O
likely	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
treated	O
with	O
a	O
six-day	O
course	O
of	O
ceftriaxone	O
transitioned	O
to	O
an	O
additional	O
day	O
of	O
cefpodoxime	O
(AM	O
and	O
___	O
on	O
___	O
on	O
discharge.	O
Urinary	O
retention	O
was	O
briefly	O
noted	O
prior	O
to	O
discharge,	O
with	O
voiding	O
trial	O
initiated	O
on	O
day	O
of	O
discharge.	O
Consideration	O
may	O
be	O
given	O
to	O
outpatient	O
Urology	O
follow-up	O
if	O
there	O
is	O
ongoing	O
concern	O
for	O
urinary	O
retention.	O
TRANSITIONAL	O
ISSUES	O
1.	O
Ongoing	O
speech	O
and	O
swallow	O
therapy	O
for	O
aphasia	O
and	O
dysphagia.	O
2.	O
Ongoing	O
blood	O
pressure	O
monitoring	O
and	O
adjustment	O
of	O
antihypertensives.	O
3.	O
Voiding	O
trial	O
___,	O
with	O
outpatient	O
Urology	O
follow-up	O
if	O
concern	O
for	O
ongoing	O
retention.	O
AHA/ASA	O
Core	O
Measures	O
for	O
Intracerebral	B-Intracranial_haemorrhage
Hemorrhage	B-Intracranial_haemorrhage
1.	O
Dysphagia	O
screening	O
before	O
any	O
PO	O
intake?	O
(X)	O
Yes	O
-	O
()	O
No.	O
If	O
no,	O
reason	O
why:	O
2.	O
DVT	O
Prophylaxis	O
administered?	O
(X)	O
Yes	O
-	O
()	O
No.	O
If	O
no,	O
why	O
not	O
(bleeding	O
risk,	O
hemorrhage,	O
etc.)	O
3.	O
Smoking	O
cessation	O
counseling	O
given?	O
()	O
Yes	O
-	O
(x)	O
No	O
[reason	O
(x)	O
non-smoker	O
-	O
()	O
unable	O
to	O
participate]	O
4.	O
Stroke	O
education	O
(personal	O
modifiable	O
risk	O
factors,	O
how	O
to	O
activate	O
EMS	O
for	O
stroke,	O
stroke	O
warning	O
signs	O
and	O
symptoms,	O
prescribed	O
medications,	O
need	O
for	O
followup)	O
given	O
(verbally	O
or	O
written)?	O
(x)	O
Yes	O
-	O
()	O
No	O
5.	O
Assessment	O
for	O
rehabilitation	O
and/or	O
rehab	O
services	O
considered?	O
(x)	O
Yes	O
-	O
()	O
No.	O
If	O
no,	O
why	O
not?	O
(I.e.	O
patient	O
at	O
baseline	O
functional	O
status)	O
Medications	O
on	O
Admission:	O
1.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
2.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
3.	O
FoLIC	O
Acid	O
1	O
mg	O
PO	O
DAILY	O
4.	O
Losartan	O
Potassium	O
100	O
mg	O
PO	O
DAILY	O
5.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
6.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
7.	O
Atorvastatin	O
10	O
mg	O
PO	O
QPM	O
8.	O
Donepezil	O
5	O
mg	O
PO	O
QHS	O
9.	O
OXcarbazepine	O
150	O
mg	O
PO	O
BID	O
10.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H:PRN	O
wheeze	O
11.	O
TraZODone	O
25	O
mg	O
PO	O
QHS	O
12.	O
Incruse	O
Ellipta	O
(umeclidinium)	O
62.5	O
mcg/actuation	O
inhalation	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Divalproex	O
(DELayed	O
Release)	O
500	O
mg	O
PO	O
BID	O
2.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H:PRN	O
wheeze	O
3.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
10	O
mg	O
PO	O
QPM	O
5.	O
Donepezil	O
5	O
mg	O
PO	O
QHS	O
6.	O
FoLIC	O
Acid	O
1	O
mg	O
PO	O
DAILY	O
7.	O
Incruse	O
Ellipta	O
(umeclidinium)	O
62.5	O
mcg/actuation	O
inhalation	O
DAILY	O
8.	O
Losartan	O
Potassium	O
100	O
mg	O
PO	O
DAILY	O
9.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
10.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
11.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
12.	O
TraZODone	O
25	O
mg	O
PO	O
QHS	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Nontraumatic	O
left	O
frontal	O
intraparenchymal	B-Intracranial_haemorrhage
hemorrhage	B-Intracranial_haemorrhage
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Confused	B-Delirium
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
You	O
were	O
transferred	O
to	O
___	O
from	O
___	O
after	O
developing	O
right	O
face	O
weakness	O
and	O
difficulty	O
speaking.	O
A	O
CT	O
scan	O
of	O
your	O
brain	O
showed	O
that	O
your	O
symptoms	O
were	O
due	O
to	O
a	O
small	O
bleed	B-Intracranial_haemorrhage
on	O
the	O
left	O
side	O
of	O
your	O
brain,	B-Intracranial_haemorrhage
which	O
remained	O
stable	O
on	O
a	O
follow-up	O
scan.	O
The	O
cause	O
of	O
your	O
bleed	B-Intracranial_haemorrhage
is	O
not	O
clear,	O
so	O
you	O
should	O
have	O
an	O
MRI	O
done	O
after	O
leaving	O
the	O
hospital	O
to	O
look	O
for	O
an	O
underlying	O
blood	O
vessel	O
problem,	O
old	O
stroke,	O
or	O
signs	O
of	O
small	O
prior	O
brain	B-Intracranial_haemorrhage
bleeds	B-Intracranial_haemorrhage
that	O
may	O
suggest	O
an	O
issue	O
with	O
the	O
blood	O
vessels	O
in	O
your	O
brain.	B-Intracranial_haemorrhage
You	O
also	O
had	O
some	O
difficulty	O
swallowing	O
safely	O
as	O
a	O
result	O
of	O
your	O
brain	B-Intracranial_haemorrhage
bleed,	B-Intracranial_haemorrhage
for	O
which	O
you	O
were	O
placed	O
on	O
a	O
modified	O
diet;	O
this	O
will	O
continue	O
to	O
be	O
reassessed	O
after	O
you	O
leave	O
the	O
hospital.	O
During	O
your	O
stay,	O
your	O
sodium	O
levels	O
were	O
noted	O
to	O
be	O
low,	O
which	O
may	O
have	O
been	O
a	O
side	O
effect	O
of	O
your	O
seizure	B-Seizures
medication	O
(oxcarbazepine).	O
This	O
medication	O
was	O
replaced	O
with	O
valproic	O
acid	O
during	O
your	O
stay,	O
without	O
concern	O
for	O
further	O
seizures.	B-Seizures
During	O
your	O
stay,	O
you	O
were	O
also	O
found	O
to	O
fevers	O
and	O
signs	O
of	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection,	B-Urinary_tract_infection
for	O
which	O
you	O
received	O
a	O
course	O
of	O
antibiotics	O
that	O
you	O
will	O
continue	O
after	O
leaving	O
the	O
hospital.	O
Please	O
follow	O
up	O
with	O
your	O
primary	O
care	O
provider	O
within	O
the	O
next	O
___	O
weeks.	O
Please	O
also	O
follow	O
up	O
with	O
Neurology	O
at	O
the	O
appointment	O
listed	O
below.	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
Sincerely,	O
___	O
Neurology	O
Followup	O
Instructions:	O
___	O

